Prognostic Factors for Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage

Background and Purpose— The purpose of this study was to describe prognostic factors for outcome in a large series of patients undergoing neurosurgical clipping of aneurysms after subarachnoid hemorrhage (SAH). Methods— Data were analyzed from 3567 patients with aneurysmal SAH enrolled in 4 randomized clinical trials between 1991 and 1997. The primary outcome measure was the Glasgow outcome scale 3 months after SAH. Multivariable logistic regression with backwards selection and Cox proportional hazards regression models were derived to define independent predictors of unfavorable outcome. Results— In multivariable analysis, unfavorable outcome was associated with increasing age, worsening neurological grade, ruptured posterior circulation aneurysm, larger aneurysm size, more SAH on admission computed tomography, intracerebral hematoma or intraventricular hemorrhage, elevated systolic blood pressure on admission, and previous diagnosis of hypertension, myocardial infarction, liver disease, or SAH. Variables present during hospitalization associated with poor outcome were temperature >38°C 8 days after SAH, use of anticonvulsants, symptomatic vasospasm, and cerebral infarction. Use of prophylactic or therapeutic hypervolemia or prophylactic-induced hypertension were associated with a lower risk of unfavorable outcome. Time from admission to surgery was significant in some models. Factors that contributed most to variation in outcome, in descending order of importance, were cerebral infarction, neurological grade, age, temperature on day 8, intraventricular hemorrhage, vasospasm, SAH, intracerebral hematoma, and history of hypertension. Conclusions— Although most prognostic factors for outcome after SAH are present on admission and are not modifiable, a substantial contribution to outcome is made by factors developing after admission and which may be more easily influenced by treatment.

[1]  K. Hoya,et al.  Acute Systemic Inflammatory Response Syndrome in Subarachnoid Hemorrhage , 2001, Stroke.

[2]  J. Öhman,et al.  Association of Apolipoprotein E Polymorphism With Outcome After Aneurysmal Subarachnoid Hemorrhage: A Preliminary Study , 2001, Stroke.

[3]  N. Kassell,et al.  Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. , 1999, Journal of neurosurgery.

[4]  Ale Algra,et al.  The Simplified Acute Physiology Score to Predict Outcome in Patients with Subarachnoid Hemorrhage , 2005, Neurosurgery.

[5]  W. Alves,et al.  A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. , 1997, Journal of neurosurgery.

[6]  A. Molyneux International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial , 2002, The Lancet.

[7]  K. Moritake,et al.  Study of aneurysmal subarachnoid hemorrhage in Izumo City, Japan. , 1995, Stroke.

[8]  William D. Dupont,et al.  Statistical Modeling for Biomedical Researchers: A Simple Introduction to the Analysis of Complex Data , 2009 .

[9]  P. Grambsch,et al.  Proportional hazards tests and diagnostics based on weighted residuals , 1994 .

[10]  H. Adams,et al.  The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. , 1990, Journal of neurosurgery.

[11]  Georg Heinze,et al.  Comparing the importance of prognostic factors in Cox and logistic regression using SAS , 2003, Comput. Methods Programs Biomed..

[12]  C. Drake,et al.  Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale. , 1988, Journal of neurosurgery.

[13]  A Pasqualin,et al.  Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa. , 1999, Journal of neurosurgery.

[14]  A. Kari,et al.  One-year outcome in early aneurysm surgery: Prediction of outcome , 2005, Acta Neurochirurgica.

[15]  H. Adams,et al.  Preoperative prognostic factors for rebleeding and survival in aneurysm patients receiving antifibrinolytic therapy: report of the Cooperative Aneurysm Study. , 1981, Neurosurgery.

[16]  L. Beenen,et al.  Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery , 1997, Journal of neurology, neurosurgery, and psychiatry.

[17]  B Jennett,et al.  Assessment of outcome after severe brain damage. , 1975, Lancet.

[18]  Aman B Patel,et al.  Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association , 1994, Stroke.

[19]  J. Marler,et al.  Measurements of acute cerebral infarction: a clinical examination scale. , 1989, Stroke.

[20]  B. Jennett,et al.  ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale , 1975, The Lancet.

[21]  W. Alves,et al.  Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. , 1996, Journal of neurosurgery.